BOA Biomedical seeks to address antibiotic resistance and sepsis

Harvard’s Wyss Institute and VC firm Miraki Innovation have created a joint venture BOA Biomedical, which is developing a device that could diagnose and treat infectious diseases.

Leave a Comment

Your email address will not be published. Required fields are marked *

Scroll to Top